The usage of biomaterials and nanoparticles in healthcare applications is increasingly common and continues to grow. Although the ambition to develop more sophisticated medical technologies, and more targeted and effective healthcare solutions, there is a risk that these materials induce undesirable reactions in the persons to be treated and even risk patient safety.
When these materials come in contact with the body, they may activate the innate immune system, which could lead to for example inflammation and thrombosis. If we could figure out what aspects of the biomaterial surface that triggers the activation, a new generation of biomaterials could be designed, and patient safety could be improved. One of the researchers addressing this issue is Karin Fromell, Associate Professor in experimental clinical immunology at the Department of Immunology, Genetics and Pathology at Uppsala University.
In an ongoing project, Assoc. Prof Fromell and her team aim to identify the connections between the activation of the innate immune response and specific properties of the biomaterial surfaces. In their work, they are also trying to identify what chemical and biochemical mechanisms are responsible for the observed activation.
The reactions involved in these processes are complex, and investigation of these immune responses requires intricate and sophisticated approaches and lab methods. In Assoc. Prof Fromell’s team, they use a whole blood model, which enables them to investigate the biocompatibility of biomaterials in vitro in human whole blood in a unique way. This is then supplemented with plasma protein profiling and physicochemical protein analysis methods, such as QCM-D to gain a broad understanding of the mechanisms behind biomaterial-triggered contact activation of the blood's cascade system, all the way down to molecular level.
In a recent webinar, Assoc. Prof. Fromell, talked about her research in this area and described how they use QCM-D to investigate the influence of key initiator proteins in the coagulation and complement systems to identify critical conditions for the formation of protein-protein complexes that prompt the activation of the cascade systems.
Watch the webinar below
Learn about how QSense analysis can be used to assess adsorption of biologics and excipients to materials used in IV-bags
Discover how QSense QCM-D technology reveals real-time cleaning insights. Join our webinar to enhance your cleaning strategies and efficiency.
Here we explain how Quartz Crystal Microbalance with Dissipation monitoring, QCM-D, works.
QSense QCM-D technology enables analysis of cleaning process dynamics, surface etching, and surface residual
Read about how and the QCM fundamental frequency matters in measurements
QCM-D was used to compare the potency and mechanisms of action of two different detergents in disrupting lipid membranes
Explore a case example of surfactant adsorption with QSense Omni, showcasing its performance and enhanced data quality.
Read about why it is important for the mass distribution on the QCM sensor to be even, and what the consequences are if it is not.
Learn more about the Sauerbrey equation and when it should be used.